Financialsexperimental
BRISTOL MYERS SQUIBB CO (CELG-RI). Every figure is as filed in the company's 10-Q and 10-K reports. Quarters a filing does not report on their own are worked out from its year-to-date figures and marked *.
USD in millions · per-share amounts in USD
| Income Statement | FY FY25 31 Dec 2025 | FY FY24 31 Dec 2024 | FY FY23 31 Dec 2023 | FY FY22 31 Dec 2022 | FY FY21 31 Dec 2021 |
|---|---|---|---|---|---|
| Total Revenues | 48,194 | 48,300 | 45,006 | 46,159 | 46,385 |
| Cost of products sold | 13,936 | 13,968 | 10,693 | 10,137 | 9,940 |
| Selling, general and administrative | 7,267 | 8,414 | 7,772 | 7,814 | 7,690 |
| Research and development | 9,951 | 11,159 | 9,299 | 9,509 | 11,354 |
| Acquired IPRD | 815 | 0 | |||
| Acquired IPRD | 3,721 | 13,373 | 913 | ||
| Amortization of acquired intangible assets | 3,317 | 8,872 | 9,047 | 9,595 | 10,023 |
| Other (income)/expense, net | 674 | 893 | -1,158 | 576 | -720 |
| Total Expenses | 38,866 | 56,679 | 36,566 | 38,446 | 38,287 |
| Earnings/(Loss) before income taxes | 9,328 | -8,379 | 8,440 | 7,713 | 8,098 |
| Income tax provision | 2,272 | 554 | 400 | 1,368 | 1,084 |
| Net earnings/(loss) | 7,055 | -8,933 | 8,040 | 6,345 | 7,014 |
| Noncontrolling Interest | 18 | 20 | |||
| Noncontrolling interest | 2 | 15 | 15 | ||
| Net earnings/(loss) attributable to BMS | 7,054 | -8,948 | 8,025 | 6,327 | 6,994 |
| Basic (usd per share) | 3.47 | -4.41 | 3.88 | 2.97 | 3.15 |
| Diluted (usd per share) | 3.46 | -4.41 | 3.86 | 2.95 | 3.12 |
| Total Revenues — Netproductsales | 45,055 | ||||
| Total Revenues — Netproductsales | 44,671 | ||||
| Total Revenues — Net Product Sales | 46,756 | 46,778 | 43,778 | ||
| Total Revenues — Allianceandotherrevenues | 1,330 | ||||
| Total Revenues — Allianceandotherrevenues | 1,488 | ||||
| Total Revenues — Alliance And Other Revenues | 1,438 | 1,522 | 1,228 |